Navigation Links
Cepheid to Present at ThinkEquity Partners 5th Annual Growth Conference
Date:9/11/2007

SUNNYVALE, Calif., Sept. 11 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) will present at the ThinkEquity Partners 5th Annual Growth Conference at the St. Regis Hotel, San Francisco, on Sept. 17, 2007. Chief Executive Officer John L. Bishop and Chief Financial Officer, John Sluis will present at 9:30 a.m. PDT.

There will be a live audio webcast of the presentation, along with accompanying presentation slides, available on Cepheid's Web site at http://www.cepheid.com under Investors: Events: Webcasts and Presentations. A replay of the webcast presentations will be available for 90 days following the event.

About Cepheid

Cepheid (Nasdaq: CPHD), based in Sunnyvale, California, is a molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the clinical, industrial and biothreat markets. The company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The company's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprietary test cartridges. Through its strong molecular biology capabilities, the company is focusing on those applications where rapid molecular testing is particularly important, such as identifying infectious disease and cancer in the clinical market; food, agricultural, and environmental testing in the industrial market; and identifying bio-terrorism agents in the biothreat market. See '/>"/>

SOURCE Cepheid
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
2. Researchers Present Ways To Reduce The Risk Of Dementia
3. Researchers Present Data Regarding The Efficiency Of Herbs
4. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
5. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
6. Drug Reactions First Present Themselves In The Mouth
7. Reminiscing Into The Past Makes You Dissatisfied With The Present
8. Living In The Past Indicates Dissatisfaction With Present
9. Movies Represent Coma In A Wrong Way
10. Onchocerciasis: Presentation And Treatment
11. Researchers Warn That Routine Physical Examination Could Miss Breech Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...ivanCotter Releases Results of Fourth Annual Physi...urvey, DETROIT, July 25 /PRNewswire/ -- Sullivan,...rth annual survey of physician on-call pay rates a...y Report. The survey report,with data from 132 he...ian,on-call pay practices and rates paid for 33 ph...
(Date:7/25/2008)... - 180-Days of Marketing Exclusivity Begin...l/ -- Watson,Pharmaceuticals, Inc. (NYSE: WPI ), ...ced today that its subsidiary has commenced commer...psules USP product in the 40mg,strength from its D...on,with the launch, Watson has 180 days of marketi...
(Date:7/25/2008)... McKesson Corporation Executive, Robert J. Reilly,...re/ -- Aethon Inc.,( http://www.aethon.com ), the ...supply chain logistics, today announced that Rober...President -- Chief Financial Officer., Reilly, wh...ger for,McKesson Corporation,s Specialty Pharmacy ...
(Date:7/25/2008)...STON, July 25 /PRNewswire/ -- The Elekta Family of...er treatment solutions at the 2008,American Associ...ing,demonstrating how the joint forces of Elekta,...on therapy planning and delivery solutions that,st...experience for,patients, as well as enhance clinic...
Breaking Medicine News(10 mins):Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 2Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 3Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2Health News:Aethon, Inc. Names New Chief Financial Officer 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3
... in the tsunami last year are eagerly expecting th...em to conceive again.// Despite having undergone ... district of Tamil Nadu in southern India will now...fter the successful performance of the surgery cal...
...y get, never lose their beauty - they merely move ...xbaum Jacqueline Saburido was a very normal girl w... // A tragic incident that occurred on the 19th of...met with a road traffic accident in which more tha...
...t to fight for receiving the new breast cancer dru... aggressive type of breast cancer and wants to mak...t that the disease is in its early stage has meant... to fund the treatment. Many women have already ta...
...Dr Michael Fenech studied the damage of excess alc...d that excess intake of // alcoholic beverages res... DNA. During the course of the study, six men age...w in plant phenols for two days, and then drank 30...
Other Medicine News:Health News:Recanalization enables Tsunami mourners to parent again 2Health News:The Looming Controversy Surrounding Facial Transplant 2
(Date:7/24/2008)...uly 24 /PRNewswire-USNewswire/ -- There are a reco...lnesses, according to a new,report released here t...ting effects that mental illnesses have on patient... illness affects nearly 60 million American,adults... and Manufacturers,of America (PhRMA), featured Em...
(Date:7/24/2008)...thermometer designed to take body temperature, for...Newswire-FirstCall/ --- Kidz-Med, Inc.,(subsidiary...: ASFX),United States distributor of the Thermofo...to announce the results of a clinical study,conduc...ity of Milan, in,Milan, Italy, which proves that t...
(Date:7/23/2008)...irst Approved Systemic Therapy to Treat the Diseas.../-,Bayer HealthCare Pharmac...NXX) today announced that The New England Journal ...emonstrating that Nexavar(R) (sorafenib),tablets d...in patients with,unresectable hepatocellular carci...
(Date:7/23/2008)...ly 23 /PRNewswire-USNewswire/ -- The following was...irman Conyers, Ranking Member Smith, and Members o...testify today., Since I appeared before this Comm...tter acquainted with the talented and dedicated pr... work they do, and I have come to,appreciate that ...
Breaking Medicine Technology:More Than 300 New Medicines Being Developed for Mental Illnesses 2More Than 300 New Medicines Being Developed for Mental Illnesses 3More Than 300 New Medicines Being Developed for Mental Illnesses 4Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3Incidental adrenal masses commonly seen on CT are usually benign 3B no follow up needed 19886 1Is extra corporal liver support with prometheus safe in patients with end stage liver disease 3F 19881 1Newly Approved Cimzia 28R 29 Provides Rapid Sustained Response in Crohns Patients 19876 1Newly Approved Cimzia 28R 29 Provides Rapid Sustained Response in Crohns Patients 19876 2Newly Approved Cimzia 28R 29 Provides Rapid Sustained Response in Crohns Patients 19876 3Newly Approved Cimzia 28R 29 Provides Rapid Sustained Response in Crohns Patients 19876 4Newly Approved Cimzia 28R 29 Provides Rapid Sustained Response in Crohns Patients 19876 5Newly Approved Cimzia 28R 29 Provides Rapid Sustained Response in Crohns Patients 19876 6Newly Approved Cimzia 28R 29 Provides Rapid Sustained Response in Crohns Patients 19876 7Newly Approved Cimzia 28R 29 Provides Rapid Sustained Response in Crohns Patients 19876 8Anthem Blue Cross Foundation Supports National Campaign Focused on Depression Among Men 19871 1Anthem Blue Cross Foundation Supports National Campaign Focused on Depression Among Men 19871 2Anthem Blue Cross Foundation Supports National Campaign Focused on Depression Among Men 19871 3
...ssional ophthalmic photographer. Integrated flash,...ground illumination, all controlled through a rele...stick, as well as adaptors allowing for the fittin...tal and 35 mm cameras, ensure ophthalmic imaging o...
...ltiplexing platform that uses advanced microarray ...sequence detection and pharmacogenetics applicatio...applied to an open and flexible electronic microar...ntil all tests sites have been utilized. This open...
...c laser platform, combining innovative laser deliv... fast operation, super adjustable Nd:YAG offset an...laser systems. ,The Nidek YC-1800 replaces th... the Joystick "Smart Switch" and One-Touch Lock.,...
epTIPS Filter have an integrated filter made of pure hydrophobic polyethylene without "self-sealing" additives. This filter provides protection against carryover and contamination caused by aerosols,
Medicine Products: